Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer.

Clinical trial NCT07730151 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07730151
Sponsor: RenJi Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostate Prostate Cancer Patients

Start date: 2026-08-01
Primary completion: 2031-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.